Molecular studies have shown that hereditary nonpolyposis colorectal carcinoma is an EC risk factor, and mutations in CTNNB (β-catenin), PI3CA (PI3K), and PTEN (phosphatase and tensin homolog) have also been reported to be EC risks. This evidence concerns the gene PTEN and hereditary nonpolyposis colorectal carcinoma.